Market Recap: Wave Life Sciences Ltd. (WVE)’s Positive Momentum, Closing at 5.79

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

The closing price of Wave Life Sciences Ltd. (NASDAQ: WVE) was $5.79 for the day, up 0.70% from the previous closing price of $5.75. In other words, the price has increased by $0.70 from its previous closing price. On the day, 0.87 million shares were traded. WVE stock price reached its highest trading level at $5.81 during the session, while it also had its lowest trading level at $5.48.


Our analysis of WVE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.26 and its Current Ratio is at 1.26. In the meantime, Its Debt-to-Equity ratio is 0.68 whereas as Long-Term Debt/Eq ratio is at 0.53.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on December 19, 2023, Upgraded its rating to Outperform and sets its target price to $12 from $5 previously.

On July 05, 2023, Raymond James started tracking the stock assigning a Outperform rating and target price of $7.

Jefferies Downgraded its Buy to Hold on May 24, 2023, whereas the target price for the stock was revised from $7 to $5.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 03 ’24 when Moran Kyle sold 15,630 shares for $6.17 per share. The transaction valued at 96,421 led to the insider holds 33,921 shares of the business.

RA CAPITAL MANAGEMENT, L.P. bought 1,000,000 shares of WVE for $5,000,000 on Dec 11 ’23. The Director now owns 19,202,009 shares after completing the transaction at $5.00 per share. On Dec 07 ’23, another insider, GSK plc, who serves as the 10% Owner of the company, bought 3,300,000 shares for $5.00 each. As a result, the insider paid 16,500,000 and bolstered with 13,983,761 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WVE now has a Market Capitalization of 708227008 and an Enterprise Value of 547666176. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.25 while its Price-to-Book (P/B) ratio in mrq is 17.41. Its current Enterprise Value per Revenue stands at 4.834 whereas that against EBITDA is -8.694.

Stock Price History:

Over the past 52 weeks, WVE has reached a high of $7.67, while it has fallen to a 52-week low of $3.15. The 50-Day Moving Average of the stock is 2.07%, while the 200-Day Moving Average is calculated to be 13.55%.

Shares Statistics:

WVE traded an average of 909.38K shares per day over the past three months and 678420 shares per day over the past ten days. A total of 119.16M shares are outstanding, with a floating share count of 96.38M. Insiders hold about 21.20% of the company’s shares, while institutions hold 74.61% stake in the company. Shares short for WVE as of 1713139200 were 3151130 with a Short Ratio of 3.47, compared to 1710460800 on 2996234. Therefore, it implies a Short% of Shares Outstanding of 3151130 and a Short% of Float of 3.7600000000000002.

Most Popular

[the_ad id="945"]